Baillie Gifford trim Recursion Pharmaceuticals, Inc.
Baillie Gifford trim $166.3M of disclosed value in Recursion Pharmaceuticals, Inc..
Signal
Investor Move
Action
Trim
Capital
$166.3M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.